A molecular and histological characterization of cartilage from patients with Morquio syndrome

Osteoarthritis and Cartilage

Volumn 15, Issue 11, 2007, Pages 1311-1317

  De Franceschi, L ^a   Roseti, L ^a   Desando, G ^a   Facchini, A ^a,b   Grigolo, B ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Chondroitin 6 sulfate; Glycosaminoglycans; Keratan sulfate; RT PCR

Indexed keywords

AGGRECAN; CHONDROITIN 6 SULFATE; COLLAGEN TYPE 1; COLLAGEN TYPE 2; KERATAN SULFATE; MATRIX PROTEIN; MESSENGER RNA; PROTEOGLYCAN;

ADULT; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE BIOPSY; CARTILAGE CELL; CELL VACUOLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; FEMUR CONDYLE; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MORQUIO SYNDROME; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; SIBLING; TISSUE STRUCTURE; VALGUS KNEE;

ADULT; AGGRECANS; BIOLOGICAL MARKERS; CARTILAGE, ARTICULAR; CHONDROCYTES; COLLAGEN TYPE I; COLLAGEN TYPE II; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MUCOPOLYSACCHARIDOSIS IV; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 35748945738     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2007.04.008     Document Type: Article

References (25)

1. Morquio L. The classics: on a form of familial osseous dystrophy. Bull Soc Pediat 27 (1929) 145-152
2. Braisford J.P. Chondro-osteo-distrophy. Roentgenographic and clinical features of a child with dislocation of vertebrae. Am J Surg 7 (1929) 404
3. Singh J., Di Ferrante N., Niebes P., and Tavella D. N-Acetylgalactosamine-6-sulfate sulfatase in man. Absence of the enzyme in Morquio disease. J Clin Invest 57 (1976) 1036-1040
4. Horwitz A.L., and Dorfman A. The enzymic defect in Morquio's disease: the specificity of N-acetylhexosamine sulfatases. Biochem Biophys Res Commun 804 (1978) 819-825
5. Matalon R., Arbogast B., Justice P., Brandt I.K., and Dorfman A. Morquio's syndrome. Deficiency of a chondroitin sulfate N-acetylhexosamine sulfate sulfatase. Biochem Biophys Res Commun 61 (1974) 709-715
6. Trojak J.E., Ho C.K., Roesel R.A., Levin L.S., Kopits S.E., Thomas G.H., et al. Morquio-like syndrome (MPS IV B) associated with deficiency of a beta-galactosidase. Johns Hopkins Med J 146 (1980) 75-79
7. van der Horst G.T., Kleijer W.J., Hoogeveen A.T., Huijmans J.G., Blom W., and van Diggelen O.P. Morquio B syndrome: a primary defect in beta-galactosidase. Am J Med Genet 16 (1983) 261-275
8. Di Ferrante N. N-Acetylglucosamine-6-sulfate sulfatase deficiency reconsidered. Science 210 (1980) 448
9. Iwata H., Tomatsu S., Fukuda S., Uchiyama A., Rezvi G.M., Ogawa T., et al. Mucopolysaccharidosis IV A: polymorphic haplotypes and informative RFLPs in the Japanese population. Hum Genet 95 (1995) 257-264
10. Rezvi G.M., Tomatsu S., Fukuda S., Yamagishi A., Cooper A., Wraith J.E., et al. Mucopolysaccharidosis IV A: a comparative study of polymorphic DNA aplotypes in the Caucasian and Japanese populations. J Inherit Metab Dis 19 (1996) 301-308
11. Tomatsu S., Fukuda S., Cooper A., Wraith J.E., Yamagishi A., Kato Z., et al. Fifteen polymorphisms in the N-acetylgalactosamine-6-sulphate sulfatase (GALNS) gene: diagnostic implications in Morquio disease. Hum Mutat 1 (1998) S42-S46
12. Tomatsu S., Montano A.M., Nishioka T., Gutierrez M.A., Pena O.M., Tranda Firescu G.G., et al. Mutation and polymorphism spectrum of the GALNS gene in mucopolysaccharidosis IVA (Morquio A). Hum Mutat 26 (2005) 500-512
13. Nelson J., and Thomas P.S. Clinical findings in 12 patients with MPS IVA (Morquio's disease). Clin Genet 33 (2005) 126-130
14. Kalteis T., Schubert T., Caro W.J., Schroder J., Luring C., and Grifka J. Arthroscopic and histological findings in Morquio's Syndrome. Arthroscopy 21 (2005) 233-237
15. Tomatsu S., Filocamo M., Orii K.O., Sly W.S., Gutierrez M.A., Nishioka T., et al. Mucopolysaccharidosis IV A (Morquio A): identification of novel common mutations in the N-acetylgalactosamine-6-sulfate sulfatase (GALNS) gene in Italian patients. Hum Mutat 24 (2004) 187-188
16. Grigolo B., Roseti L., Neri S., Gobbi P., Jensen P., Major E.O., et al. Human articular chondrocytes immortalized by HPV-16 E6 and E7 genes: maintenance of differentiated phenotype under defined culture conditions. Osteoarthritis Cartilage 10 (2002) 879-889
17. Martin I., Jakob M., Schäfer D., Dick W., Spagnoli G., and Heberer M. Quantitative analysis of gene expression in human articular cartilage from normal and osteoarthritic joints. Osteoarthritis Cartilage 9 (2001) 112-118
18. Grigolo B., Roseti L., Fiorini M., Piacentini A., De Franceschi L., and Facchini A. Cathepsin B as a soluble marker to monitor the phenotypic stability of engineered cartilage. Biomaterials 24 (2003) 1751-1757
19. Blanco F.J., Geng Y., and Lotz M. Differentiation-dependent effects of IL-1 and TGF-β on human articular chondrocyte proliferation are related to inducible nitric oxide synthase expression. J Immunol 154 (1995) 4018-4026
20. Mikles M., and Stanton R.P. A review of Morquio syndrome. Am J Orthop 26 (1997) 533-540
21. Luyten F.P., Hascall V.C., Nissley S.P., Morales T.I., and Reddi A.H. Insulin-like growth factors maintain steady-state metabolism of proteoglycans in bovine articular cartilage explants. Arch Biochem Biophys 267 (1988) 416-425
22. Fukuda S., Tomatsu S., Masue M., Sukegawa K., Iwata H., Ogawa T., et al. Mucopolysaccharidosis type IVA. N-Acetylgalactosamine-6-sulfate sulfatase exonic point mutations in classical Morquio and mild cases. J Clin Invest 90 (1992) 1049-1053
23. Maroudas A., and Schneidermann R. Free and exchangeable or trapped and non-exchangeable water in cartilage. J Orthop Res 5 (1987) 133-138
24. Mayne R., and Irwin M.H. Collagen types in cartilage. In: Kuettner K.E., Schleyerbach R., and Hascall V.C. (Eds). Articular Cartilage Biochemistry (1986), Raven Press, New York 23-28
25. Lind M., and Bünger C. Orthopaedic applications of gene therapy. Int Orthop 29 (2005) 205-209